🔎 Trials Near Me

Hjem › Akut myelogen leukemi › Tennessee › Memphis

Kliniske studier for Akut myelogen leukemi i Memphis, TN

15 studier for Akut myelogen leukemi søker deltakere på steder i og rundt Memphis (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

RekruttererFase 2
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi unna
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT05564390

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

RekruttererFase 2
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi unna
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi unna
Alder 18 til 59 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT05554393

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

RekruttererFase 2
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi unna
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi unna
Alder 18 til 59 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

RekruttererFase 2
  • Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
  • Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi unna
  • Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06317649

A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia

RekruttererFase 2
  • St. Jude Children's Research Hospital, Memphis
29 Days – 21 Years · Alle kjønn · Oppdatert 17. sep. 2026 · NCT05955261

A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia

RekruttererFase 1
  • St. Jude Children's Research Hospital, Memphis
Opp til 25 år · Alle kjønn · Oppdatert 15. sep. 2026 · NCT06810583

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

RekruttererFase 3
  • St. Jude Children's Research Hospital, Memphis
29 Days – 21 Years · Alle kjønn · Oppdatert 24. aug. 2026 · NCT05183035

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

RekruttererFase 3
  • Baptist Clinical Research Institute, Memphis
Alder 18 og eldre · Alle kjønn · Oppdatert 20. aug. 2026 · NCT07007312

Eltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia

RekruttererFase 1
  • Baptist Health Care Corporation, Memphis
Alder 18 og eldre · Alle kjønn · Oppdatert 19. aug. 2026 · NCT06399640

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

RekruttererFase 1
  • St. Jude Children's Research Hospital, Memphis
Alder 1 til 30 · Alle kjønn · Oppdatert 3. aug. 2026 · NCT06177067

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RekruttererObservasjonsstudie
  • St. Jude Childrens Research Hospital, Memphis
Alle aldre · Alle kjønn · Oppdatert 6. jul. 2026 · NCT01351545

Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy

RekruttererFase 1
  • St. Jude Children's Research Hospital, Memphis
Opp til 21 år · Alle kjønn · Oppdatert 22. apr. 2026 · NCT05101551

CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies

RekruttererFase 1
  • St. Jude Children's Research Hospital, Memphis
Opp til 21 år · Alle kjønn · Oppdatert 23. jan. 2026 · NCT06326463

Akut myelogen leukemi-studier i andre byer

Andre studier i Memphis

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.